Lacosamide Injection
Product Images NDC 72603-263

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 72603-263). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aspiro (Aspiro)

FDA Label Image

Lacosamide-inj-fig-1 (Lacosamide Inj Fig 1)

Lacosamide-inj-fig-1 (Lacosamide Inj Fig 1)
A bar graph comparing seizure reduction (median percentage change from baseline) in three separate studies labeled Study 2, Study 3, and Study 4. Each study compares placebo with different daily doses of Lacosamide (200, 400, and 600 mg/day). The graph shows Lacosamide at all dosages with higher median seizure reductions than placebo, with asterisks indicating statistically significant differences versus placebo.*
FDA Label Image

Lacosamide-inj-fig-2 (Lacosamide Inj Fig 2)

Lacosamide-inj-fig-2 (Lacosamide Inj Fig 2)
A responder rate curve chart showing improvement and worsening in patient response to different doses of lacosamide injection versus placebo. The x-axis represents percent of patients, and the y-axis displays responder rate from -100% (worsening) to 100% (improvement). Four curves compare placebo and lacosamide doses of 200 mg/day, 400 mg/day, and 600 mg/day.*
FDA Label Image

Lacosamide-inj-structure (Lacosamide Inj Structure)

Lacosamide-inj-structure (Lacosamide Inj Structure)
Chemical structure of lacosamide, showing its molecular formula with acetyl, methoxy, amide, and benzyl functional groups clearly depicted.*
FDA Label Image

Lacosamideviallabel10mgml (Lacosamide Vial Label 10 mg mL)

Lacosamideviallabel10mgml (Lacosamide Vial Label 10 mg mL)
Label for Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL) intravenous single-dose vial by NorthStar Rx LLC. The label indicates storage between 20°C to 25°C, provides a pharmacist medication guide notice, barcode, batch coding area, and manufacturing details for Aspiro Pharma Limited, India.*
FDA Label Image

Lacosamidevialcarton10mgml. (Lacosamidevialcarton10mgml)

Lacosamidevialcarton10mgml. (Lacosamidevialcarton10mgml)
Box packaging for Lacosamide Injection, USP, 200 mg/20 mL (10 mg/mL) intravenous solution. Each box contains 10 single-dose 20 mL vials. Label shows dosing strength, pharmacist instructions to dispense medication guide, storage information, and manufacturer details from NorthStar RxLLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.